top of page

Revlimid Capsules 10mg

Product details

Registration number: SIN13663P

Classification: Prescription Only

Active ingredients: Lenalidomide

Strength: 10.0 mg

Dosage form: CAPSULE

Route: ORAL

Registrant: BRISTOL-MYERS SQUIBB (SINGAPORE) PTE. LTD.

ATC code: L04AX04

HSA approval date: 23 June 2009

Manufacturer(s): Celgene International Sarl

Manufacturing country/countries: SWITZERLAND

What are the HSA registration number and classification for Revlimid Capsules 10mg?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN13663P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for Revlimid Capsules 10mg?

According to the HSA dataset updated 7 August 2026:

Active ingredients: Lenalidomide

Strength: 10.0 mg

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for Revlimid Capsules 10mg?

According to the HSA dataset updated 7 August 2026:

Dosage form: CAPSULE

Route: ORAL

Source for this answer

Who is the recorded registrant for Revlimid Capsules 10mg?

According to the HSA dataset updated 7 August 2026:

Registrant: BRISTOL-MYERS SQUIBB (SINGAPORE) PTE. LTD.

Source for this answer

Which manufacturers and countries are listed for Revlimid Capsules 10mg?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s): Celgene International Sarl

Manufacturing country/countries: SWITZERLAND

Source for this answer

Where can I look up Revlimid Capsules 10mg in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN13663P or the exact product name Revlimid Capsules 10mg. The general register link does not preselect this product.

Source for this answer

What are the source dates for this Revlimid Capsules 10mg record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this Revlimid Capsules 10mg record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN13663P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page